Turk J Haematol 2013 Jun;30(2):211-3

Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia.

Eşkazan AE1, Soysal T2.
Error occured. Please try again later.
ase try again later.